Related Experiment Videos
Evaluating and comparing imaging techniques: a review and classification of study designs.
1MRC Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Cambridge.
The British Journal of Radiology
|November 1, 1987
Summary
This review outlines study designs for evaluating diagnostic imaging accuracy and clinical value. It recommends prioritizing clinical value (Phase III) studies over diagnostic accuracy (Phase II) designs for better patient management insights.
Area of Science:
- Medical Imaging
- Clinical Study Design
- Health Technology Assessment
Background:
- Evaluating imaging techniques requires robust study designs.
- Existing designs often focus on diagnostic accuracy, not clinical impact.
- The "independence principle" limits the assessment of a technique's contribution to patient care.
Purpose of the Study:
- To review and classify study designs for evaluating imaging techniques.
- To differentiate between diagnostic accuracy and clinical value study designs.
- To emphasize the need for more clinical value-focused research.
Main Methods:
- Review of existing literature on study designs for imaging techniques.
- Proposal of a classification system for study designs.
- Analogy drawn between diagnostic accuracy studies and Phase II clinical trials.
- Analogy drawn between clinical value studies and Phase III clinical trials.
Main Results:
- Thirteen principles for designing diagnostic accuracy studies are presented.
- Diagnostic accuracy studies are analogous to Phase II trials.
- Clinical value studies, recommended for assessing management contribution, are analogous to Phase III trials.
- The majority of published studies currently utilize Phase II designs.
Conclusions:
- A clear distinction exists between diagnostic accuracy and clinical value study designs.
- Clinical value (Phase III) studies are crucial for understanding the real-world impact of imaging techniques.
- Increased emphasis on Phase III study designs is necessary for advancing patient care through medical imaging.